Trial intelligence / Profile preview

Autologous MSCs for Knee Cartilage Repair

NCT02118519Phase 2Completed

Sponsor
University of Jordan
Start
Jan 2014
Primary completion
Aug 2015
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous mesenchymal stem cells in knee osteoarthritis (OA), Articular cartilage disorder, sponsored by University of Jordan. Started Jan 2014; status: completed.

02

Drugs

autologous mesenchymal stem cells
03

Conditions

knee osteoarthritis (OA)Articular cartilage disorder

Beyond the preview

Go deeper on NCT02118519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02118519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call